7263 articles
A multinational study of 4,913 patients finds EBRT delivers survival outcomes comparable to surgery and ablation for early hepatocellular carcinoma.
Adding targeted radiation to standard therapy reduced progression by 46% across multiple cancer types in the EXTEND trial.
A randomized trial shows hormone receptor-positive/HER2+ early breast cancer patients had 100% 5-year overall survival with endocrine therapy plus dual HER2 blockade.
Researchers propose targeting lymph node entry mechanisms to improve immune tolerance in cardiac transplant recipients, potentially reducing rejection.
Cas13-based RNA editing shows promise for treating hereditary hypertrophic cardiomyopathy by correcting disease-causing mutations at the RNA level.
A Circulation review from Harvard proposes the 'target trial framework' to improve how observational data is used to assess cardiovascular device safety and effectiveness.
A spatial proteomics platform profiled 700,000+ brain cells, identifying a microglial subset that clusters around amyloid-Ξ² plaques in Alzheimer's disease.
A new deep learning model from UCSF predicts Alzheimer's diagnosis and cognitive trajectories from one MRI scanβno expensive multimodal imaging required.
Behavioral scientist Dr. Nick Epley reveals how everyday social moments with strangers improve mental and physical health.
A key m6A RNA modifier enables colorectal cancer cells to resist chemotherapy by stabilizing a transcription factor that regulates iron homeostasis.
Ξ±KG supplementation restores glutamine metabolism and halts cartilage destruction in OA models through H3K27me3 demethylation.
A landmark review reveals why aging immune systems lose the ability to clear senescent cells β and how new therapies could restore this critical defense.
